Pathophysiological basis of the cardiological benefits of SGLT-2 inhibitors: a narrative review.
Panico C, Bonora B, Camera A, Chilelli NC, Prato GD, Favacchio G, Grancini V, Resi V, Rondinelli M, Zarra E, Pintaudi B.
Panico C, et al. Among authors: grancini v.
Cardiovasc Diabetol. 2023 Jun 30;22(1):164. doi: 10.1186/s12933-023-01855-y.
Cardiovasc Diabetol. 2023.
PMID: 37391739
Free PMC article.
Review.